Report: Peninsula cell therapy company explores sale

Gilead or Takeda could be interested in the San Carlos company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.